|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1999-11-30
|
|
pubmed:abstractText |
To evaluate 1) the effect of the tumor treatment on the clinical course of paraneoplastic encephalomyelitis (PEM) with anti-Hu antibodies, 2) the impact of immunotherapy on the tumor evolution, and 3) the outcome of the small cell lung cancer (SCLC) of PEM patients compared with that of patients without PEM.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1719-23
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10563618-Adult,
pubmed-meshheading:10563618-Aged,
pubmed-meshheading:10563618-Antibodies,
pubmed-meshheading:10563618-Carcinoma, Small Cell,
pubmed-meshheading:10563618-Disease Progression,
pubmed-meshheading:10563618-Encephalomyelitis,
pubmed-meshheading:10563618-Female,
pubmed-meshheading:10563618-Hu Paraneoplastic Encephalomyelitis Antigens,
pubmed-meshheading:10563618-Humans,
pubmed-meshheading:10563618-Immunotherapy,
pubmed-meshheading:10563618-Lung Neoplasms,
pubmed-meshheading:10563618-Male,
pubmed-meshheading:10563618-Middle Aged,
pubmed-meshheading:10563618-Nerve Tissue Proteins,
pubmed-meshheading:10563618-Paraneoplastic Syndromes,
pubmed-meshheading:10563618-RNA-Binding Proteins,
pubmed-meshheading:10563618-Retrospective Studies,
pubmed-meshheading:10563618-Survival Analysis,
pubmed-meshheading:10563618-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.
|
|
pubmed:affiliation |
Services of Neurology, Hôpital de la Salpêtrière, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
